Philippe Devillier

Discipline

Sciences de l'information et de la communication (30) Economies et finances (7) Psychologie (5) Linguistique (3) Sociologie (1) Anthropologie biologique (1)

Discipline

Sciences de l'information et de la communication (3) Linguistique (1) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (66) Colloques et conférences (23)

Type de document

Articles (15)

Co-auteur

Auteur

Date

Date

Source

Source

Mot-clé

Social sciences (67) Science (67) Patients (33) Patients (32) Treatment (27) Asthma (27) Methods (23) Methods (23) France (22) Science (22) Ciencias (22) Publics (22) Sciences (22) France (22) Hay fever (20) Allergy (17) Immunotherapy (17) Paris (16) Paris (16) allergie (15) maladie (15) Immunotherapy (15) maladie (15) allergène (13) Impact (12) analyse (11) Analysis (11) Symptoms (10) Rhinitis (10) Lungs (10)

Mot-clé

Social sciences (12) Science (12) Asthma (10) Control (6) allergie (5) Rhinitis (5) Hay fever (5) Allergy (5) technologie (4) Methods (4) Technology (4) Methods (4) Technology (4) Patients (4) Treatment (3) Care (3) Work (3) Symptoms (3) Patients (3) Impact (3) Evaluation (3) Drug utilization (3) Days (3) Science (3) Ciencias (3) Publics (3) Sciences (3) roman (3) puits (2) productivité (2)

Documents écrit par Philippe Devillier (89) | parle de Philippe Devillier (15)

Residual reversibility in COPD patients already on long-acting bronchodilator: The OscilloRevers Study
Olivier Le Rouzic et al.
Pharmacogénétique de l’asthme
Philippe Devillier (26 janv. 2024)
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort
Philippe Devillier et al. (19 déc. 2023)
Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis
Oliver Pfaar et al. (18 déc. 2023)
A benchmark study of data normalisation methods for PTR-TOF-MS exhaled breath metabolomics
Camille Roquencourt et al. (10 nov. 2023)
Enhanced real-time mass spectrometry breath analysis for the diagnosis of COVID-19
Camille Roquencourt et al. (29 sept. 2023)
Enhanced real-time mass spectrometry breath analysis for the diagnosis of COVID-19
Camille Roquencourt et al. (18 sept. 2023)
Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies
Oliver Pfaar et al.
Les différents corticoïdes inhalés dans l’asthme, quels avantages respectifs ?
Philippe Devillier (26 avr. 2023)
Prise en charge pharmacologique de la rhinite allergique
Philippe Devillier (1 avr. 2023)
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Bernardo Sousa-Pinto et al.
Patient‐reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life
Farah Bahbah et al.
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK ‐air® longitudinal study
Bernardo Sousa-Pinto et al.
Traitement de la rhinite allergique: voie nasale versus per os.
Philippe Devillier (17 mars 2023)
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach
Jean Bousquet et al.
Nouveaux concepts de prise en charge de l’asthme, 7 à vous de juger !
Philippe Devillier (8 déc. 2022)
Patient obèse, fumeur : mythe médecin ou réalité patient
Philippe Devillier (8 déc. 2022)
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Bernardo Sousa-Pinto et al.
Les grands principes de la prise en charge de la BPCO par les traitements inhalés : 1,2,3,…
Philippe Devillier (13 oct. 2022)
Comparison of rhinitis treatments using MASK ‐air® data and considering the minimal important difference
Bernardo Sousa-Pinto et al.
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air ® real‐world data
Bernardo Sousa-Pinto et al.
Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability
Nikola Mantov et al. (19 août 2022)
Development and validation of combined symptom‐medication scores for allergic rhinitis*
Bernardo Sousa-Pinto et al.
Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate‐to‐severe allergy
Michael Blaiss et al.
Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021
Maeva Zysman et al.

next
Principaux messages de la première Biennale BPCO 2021 de la SPLF. Mieux comprendre pour innover
J. Ancel et al.
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air
Bernardo Sousa-Pinto et al.
Evaluating response to biologics in severe asthma: Precision or guesstimation?
C. Taillé et al.
Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021
M. Zysman et al.
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
A. Bédard et al.
How can we minimise the use of regular oral corticosteroids in asthma?
Arnaud Bourdin et al. (5 févr. 2020)
A marine-sourced fucoidan solution inhibits Toll-like-receptor-3-induced cytokine release by human bronchial epithelial cells
M. Dutot et al.
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
J. Bousquet et al.
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
J. Bousquet et al.
Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study
J. Bousquet et al.
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
J. Bousquet et al.
Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals
Guillemette Unal et al. (1 juin 2018)
Observance du traitement de fond dans l’asthme persistant de l’adulte en pratique courante
P. Devillier et al.
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study
J. Bousquet et al.
Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis
S. Zielen et al.